Vanguard Personalized Indexing Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $769K | Sell |
13,993
-10,433
| -43% | -$574K | 0.01% | 1004 |
|
|
2025
Q1 | $1.73M | Buy |
24,426
+2,550
| +12% | +$180K | 0.03% | 547 |
|
|
2024
Q4 | $1.44M | Buy |
21,876
+4,888
| +29% | +$321K | 0.02% | 604 |
|
|
2024
Q3 | $1.19M | Buy |
16,988
+6,357
| +60% | +$447K | 0.02% | 685 |
|
|
2024
Q2 | $875K | Buy |
10,631
+1,356
| +15% | +$112K | 0.02% | 741 |
|
|
2024
Q1 | $810K | Sell |
9,275
-26
| -0.3% | -$2.27K | 0.02% | 767 |
|
|
2023
Q4 | $897K | Sell |
9,301
-1,565
| -14% | -$151K | 0.02% | 716 |
|
|
2023
Q3 | $961K | Sell |
10,866
-850
| -7% | -$75.2K | 0.03% | 576 |
|
|
2023
Q2 | $1.02M | Buy |
11,716
+436
| +4% | +$37.8K | 0.03% | 559 |
|
|
2023
Q1 | $1.1M | Sell |
11,280
-184
| -2% | -$17.9K | 0.04% | 485 |
|
|
2022
Q4 | $1.19M | Sell |
11,464
-126
| -1% | -$13K | 0.05% | 442 |
|
|
2022
Q3 | $982K | Buy |
11,590
+2,472
| +27% | +$209K | 0.04% | 486 |
|
|
2022
Q2 | $756K | Buy |
9,118
+5,111
| +128% | +$424K | 0.04% | 603 |
|
|
2022
Q1 | $309K | Sell |
4,007
-4
| -0.1% | -$308 | 0.02% | 990 |
|
|
2021
Q4 | $354K | Buy |
+4,011
| New | +$354K | 0.02% | 819 |
|
|
2021
Q3 | – | Sell |
-4,294
| Closed | -$358K | – | 986 |
|
|
2021
Q2 | $358K | Buy |
+4,294
| New | +$358K | 0.04% | 656 |
|